Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RITUXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title AIMOVIG
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ETORICOXIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NEMLUVIO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RINVOQ
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RITUXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REMODULIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OCREVUS ZUNOVO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title AMBRISENTAN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TECVAYLI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LACTULOSE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title BECLOMETHASONE DIPROPIONATE\FORMOTEROL FUMARATE\GLYCOPYRROLATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND KWIKPEN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FOUNDAYO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND KWIKPEN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FOUNDAYO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VERZENIO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title MOUNJARO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PALIPERIDONE PALMITATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FAMOTIDINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FOSFOMYCIN SODIUM
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title INFLIXIMAB-DYYB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology